Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre

British Journal of Haematology

Volumn 145, Issue 1, 2009, Pages 40-44

  Stevens, Jane M ^a   MacDougall, Finlay ^a   Jenner, Michael ^a   Oakervee, Heather ^a   Cavenagh, Jamie ^a   Lister, Andrew T ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Clinical trial; Trial recruitment

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CANCER SURVIVAL; CLINICAL EVALUATION; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SATISFACTION; PATIENT SELECTION; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SELECTION BIAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61849181538     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07561.x     Document Type: Article

References (10)

1. Cottin, V., Arpin, D., Lasset, C., Cordier, J.F., Brune, J., Chauvin, F. Trillet-Lenoir, V. (1999) Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. Annals of Oncology, 10, 809 815.
2. Crowther, D., Powles, R.L., Bateman, C.J., Beard, M.E., Gauci, C.L., Wrigley, P.F., Malpas, J.S., Fairley, G.H. Scott, R.B. (1973) Management of adult acute myelogenous leukaemia. British Medical Journal, 1, 131 137.
3. Ellison, R.R., Holland, J.F., Weil, M., Jacquillat, C., Boiron, M., Bernard, J., Sawitsky, A., Rosner, F., Gussoff, B., Silver, R.T., Karanas, A., Cuttner, J., Spurr, C.L., Hayes, D.M., Blom, J., Leone, L.A., Haurani, F., Kyle, R., Hutchison, J.L., Forcier, R.J. Moon, J.H. (1968) Arabinosyl cytosine: a useful agent in the treatment of acute leukaemia in adults. Blood, 33, 507 523.
4. Estey, E. Dohner, H. (2006) Acute myeloid leukaemia. Lancet, 368, 1894 1907.
5. Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K., Wheatley, K., Gray, R.G. Burnett, A.K. (1997) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood, 89, 2311 2318.
6. Mayers, C., Panzarella, T. Tannock, I.F. (2001) Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma. Cancer, 91, 2246 2257.
7. Mengis, C., Aebi, S., Tobler, A., Dahler, W. Fey, M.F. (2003) Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials. Journal of Clinical Oncology, 21, 3933 3939.
8. Moorman, A.V., Roman, E., Cartwright, R.A. Morgan, G.J. (2002) Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK. Clinical and Laboratory Haematology, 24, 263 265.
9. Rohatiner, A.Z.S., Bassan, R., Bjorkholm, M., Rule, S., Newland, A.C., Raimondi, R., Carter, M. Lister, A.T. (1998) High-dose treatment with peripheral blood progenitor cell support as consolidation of first remission in younger patients with acute myeloid leukaemia. Blood, 92 (10 Suppl. 1 1198.
10. Swirsky, D.M., de Bastos, M., Parish, S.E., Rees, J.K. Hayhoe, F.G. (1986) Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients. British Journal of Haematology, 64, 435 453.